Tue, June 21, 2022

Raghuram Selvaraju Maintained (AQST) at Strong Buy with Decreased Target to $5 on, Jun 21st, 2022

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Aquestive Therapeutics, Inc." (AQST) at Strong Buy with Decreased Target from $8 to $5 on, Jun 21st, 2022.

Raghuram, nor any peers, have made any analyst calls on AQST in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30